DNA Nanobots raises $3.5m to push non-viral gene delivery T
Business Wire - 17-Dec-2025Fresh funding backs DNA origami nanobots aimed at safer, more precise gene therapies
Previously the Live Forever Club — same community, now with a sharper mission for life extension
News provider covering business including public relations, investor relations and distribution & analytics
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure.
Public relations, investor relations, public policy, and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.
Founded in 1961, Business Wire is a trusted source for news organizations, journalists, investment professionals, and regulatory authorities, delivering news directly into editorial systems and leading online news sources via its multi-patented NX Network. Business Wire’s global newsrooms are available to meet the needs of communications professionals and news media worldwide.
Visit website: https://www.businesswire.com/portal/site/home/
Details last updated 04-Feb-2019
Fresh funding backs DNA origami nanobots aimed at safer, more precise gene therapies
First GPX4 modulator enters human trials to target senescent cells and combat skin aging
Synergy of Fisetin, Urolithin A, and Ergothioneine for anti-ageing
Research underscores potential to revolutionise approach to healthy ageing
Tiny robots made of DNA can now deliver your medicine straight to the cells
It improved muscles and slowed down the disease in animals
It's based on sirtuins research and claims to provide visible results in 14 days
Refreshed brand offers end-to-end mental health support, from mindfulness to therapy and psychiatry
Unlocking the secrets of cancer and genetic diseases with nanopore sequencing
Lead program targets TRPV4, an ion channel that is involved in several diseases
Rubedo is planning first-in-human studies in multiple skin indications driven by chronic inflammation
Cell therapies aiming not only to correct the genetic defect but also repair and heal the muscle cells
Aims to treat age-related diseases using advanced cellular reprogramming technologies
Sarcopenia drug trial shows no evidence of toxicity or safety issues
Mitopure can improve mitochondrial health and counteract age-related muscle function decline
Liver ICU main aim-Improve liver transplant processes and discover therapies for liver diseases
Ultra-low toxicity NaNots could have a wide variety of applications
Through stimulating deeper parts of brain, patients can feel and control their limbs
Both companies to continue with the diverse technologies and product development
Convergence of genomic technologies and machine learning digitizes liver biology
Relays all information & reports to offer real time solutions to physician problems
Will begin clinical trials after completing pre-clinical studies
Studies were done by integrating whole-genome sequencing with advanced imaging and blood metabolites
Antoxerene partners with Juvenescence to discover drugs that clear senescent cells
Study that reveals genes implicated in tissue regeneration, cancer, and aging. Worked in collabo...
A nanotechnology-based solution to bring new hope to millions of blind and visually-impaired
DNA and gut microbiome tests with integrated analysis on the company’s health platform. Select p...
Relaunches as a clinical-stage company, with phase 1 clinical trials of lead compound for Alzheimer’s
Modular surgical system that uses multiple collaborative robotic arms for universal minimal acces...